CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,046,482 | -27.1% | 111,818 | -40.4% | 0.00% | 0.0% |
| Q2 2023 | $4,177,082 | +45.3% | 187,734 | +41.5% | 0.00% | +200.0% |
| Q1 2023 | $2,873,978 | +89.3% | 132,686 | +77.5% | 0.00% | 0.0% |
| Q4 2022 | $1,518,335 | -60.8% | 74,758 | -50.5% | 0.00% | -66.7% |
| Q3 2022 | $3,870,000 | +64.8% | 150,935 | +52.8% | 0.00% | +200.0% |
| Q2 2022 | $2,349,000 | +1.0% | 98,767 | -4.3% | 0.00% | 0.0% |
| Q1 2022 | $2,325,000 | +30.8% | 103,241 | +15.0% | 0.00% | 0.0% |
| Q4 2021 | $1,777,000 | +3.4% | 89,753 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $1,719,000 | -11.5% | 87,357 | -1.1% | 0.00% | 0.0% |
| Q2 2021 | $1,943,000 | +104.5% | 88,321 | +121.1% | 0.00% | 0.0% |
| Q1 2021 | $950,000 | -63.4% | 39,948 | -59.8% | 0.00% | 0.0% |
| Q4 2020 | $2,599,000 | +8.8% | 99,326 | -27.6% | 0.00% | 0.0% |
| Q3 2020 | $2,388,000 | -23.4% | 137,226 | -26.0% | 0.00% | -66.7% |
| Q2 2020 | $3,119,000 | +86.4% | 185,450 | +31.8% | 0.00% | +200.0% |
| Q1 2020 | $1,673,000 | -58.2% | 140,708 | -57.5% | 0.00% | -66.7% |
| Q4 2019 | $4,006,000 | +22.7% | 331,090 | +43.4% | 0.00% | 0.0% |
| Q3 2019 | $3,264,000 | +44.4% | 230,834 | +13.8% | 0.00% | +50.0% |
| Q2 2019 | $2,261,000 | -31.6% | 202,899 | -28.0% | 0.00% | -33.3% |
| Q1 2019 | $3,306,000 | -31.7% | 281,695 | -22.2% | 0.00% | -40.0% |
| Q4 2018 | $4,840,000 | +171.0% | 362,293 | +184.4% | 0.01% | +400.0% |
| Q3 2018 | $1,786,000 | -57.3% | 127,409 | -52.1% | 0.00% | -66.7% |
| Q2 2018 | $4,185,000 | +2.9% | 266,235 | +7.7% | 0.00% | -25.0% |
| Q1 2018 | $4,066,000 | -33.4% | 247,155 | -26.9% | 0.00% | -33.3% |
| Q4 2017 | $6,109,000 | +29.0% | 338,292 | +37.9% | 0.01% | +50.0% |
| Q3 2017 | $4,735,000 | +129.1% | 245,318 | +40.0% | 0.00% | +100.0% |
| Q2 2017 | $2,067,000 | +617.7% | 175,214 | +566.3% | 0.00% | – |
| Q1 2017 | $288,000 | -47.5% | 26,296 | -65.2% | 0.00% | – |
| Q4 2016 | $549,000 | +224.9% | 75,663 | +191.3% | 0.00% | – |
| Q3 2016 | $169,000 | +92.0% | 25,973 | +62.5% | 0.00% | – |
| Q2 2016 | $88,000 | -65.6% | 15,983 | -70.8% | 0.00% | – |
| Q1 2016 | $256,000 | +75.3% | 54,739 | +87.0% | 0.00% | – |
| Q4 2015 | $146,000 | – | 29,272 | +292620.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 10 | -98.8% | 0.00% | – |
| Q2 2015 | $5,000 | -82.8% | 804 | -84.5% | 0.00% | – |
| Q1 2015 | $29,000 | +7.4% | 5,178 | -43.4% | 0.00% | – |
| Q4 2014 | $27,000 | +440.0% | 9,156 | +393.6% | 0.00% | – |
| Q3 2014 | $5,000 | +66.7% | 1,855 | +95.1% | 0.00% | – |
| Q2 2014 | $3,000 | -92.1% | 951 | -89.1% | 0.00% | – |
| Q1 2014 | $38,000 | -29.6% | 8,756 | -47.5% | 0.00% | – |
| Q4 2013 | $54,000 | – | 16,675 | +23385.9% | 0.00% | – |
| Q3 2013 | $0 | – | 71 | +1.4% | 0.00% | – |
| Q2 2013 | $0 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |